Read article Where this ovarian cancer information comes from
This page tells you about the major sources of information that we used to put together the ovarian cancer section.
All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had ovarian cancer, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.
Cancer Research UK
CancerStats
US National Cancer Institute
Information on the treatment of ovarian cancer
www.cancer.gov/cancertopics/types/ovarian
Principles and practice of oncology (8th edition)
De Vita, V.T., Hellman, S. and Rosenberg S.A.
Lippincott, Williams and Wilkins, 2008
Cancer and its management (6th edition)
Tobias J. and Hochhauser D.
Blackwell Publishing Ltd, 2010
The recognition and initial management of ovarian cancer.
The National Institute for Health and Clinical Excellence (NICE), April 2011
Link to the NICE website
Epithelial Ovarian Cancer
Scottish Intercollegiate Guidelines Network (SIGN), October 2003
Link to the SIGN website
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for the treatment of advanced ovarian cancer.
The National Institute for Health and Clinical Excellence (NICE), May 2005
Link to the NICE website
Guidance on the use of paclitaxel for ovarian cancer. NICE.
The National Institute for Health and Clinical Excellence (NICE), January 2003
Link to the NICE website
Ovarian cysts in postmenopausal women
Royal College of Obstetricans and Gynaecologists
Guideline No 34, Oct 2003
Bevacizumab in combination with carboplatin and paclitaxel for the front-line treatment of advanced (International Federation of Gynaecology and Obstetrics [FIGO] stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Scottish Medicines Consortium, September 2012, SMC No. (806/12)
Link to SMC website
Ovarian cancer and hormone replacement therapy in the Million Women Study. Million Women Study Collaborators. The Lancet 2007;369: 1703-10.
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Jaaback K, Johnson N. Cochrane Database of Systematic Reviews, 2006, Issue 1.
Chemotherapy for advanced ovarian cancer. Stewart L, Advanced Ovarian Cancer Trialists Group. Cochrane Database of Systematic Reviews 1999, Issue 1.
Interval debulking surgery for advanced epithelial ovarian cancer. Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P. Cochrane Database of Systematic Reviews, 2009, Issue 1.
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA, Kitchener HC, Dickinson HO. Cochrane Database of Systematic Reviews, 2009, Issue 1.
Professor Jonathan Ledermann, Professor of medical oncology
Mr Robin Crawford, MD, FRCS, MRCOG
Professor Ian Jacobs, MD, MRCOG
Dr Timothy Perren MD, FRCP
Beverley Hicks, Patient reviewer
Dee McLean - MeDee Art, Medical Illustrations
- Share this: Tweet
-
-
- Print this page
-
Email this page
Increase text size
Decrease text size
Print page
Print basket
Save pages here and print in one go
Nurse helpline
Questions about cancer? Call freephone
0808 800 4040
or email us
